-
3
-
-
33746468121
-
Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: Implications for Alzheimer's disease
-
Abdul HM, Calabrese V, Calvani M, Butterfield DA (2006) Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease. J Neurosci Res 84(2):398-408
-
(2006)
J Neurosci Res
, vol.84
, Issue.2
, pp. 398-408
-
-
Abdul, H.M.1
Calabrese, V.2
Calvani, M.3
Butterfield, D.A.4
-
4
-
-
0029858216
-
Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease
-
Levy ML, Cummings JL, Fairbanks LA, Bravi D, Calvani M, Carta A (1996) Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease. Am J Psychiatry 153(11):1438-1443
-
(1996)
Am J Psychiatry
, vol.153
, Issue.11
, pp. 1438-1443
-
-
Levy, M.L.1
Cummings, J.L.2
Fairbanks, L.A.3
Bravi, D.4
Calvani, M.5
Carta, A.6
-
5
-
-
0016644462
-
Amyloidosis, expression and cause of presenile and senile mental and physical regression. A revision of the amyloid problem
-
Schwartz P (1975) Amyloidosis, expression and cause of presenile and senile mental and physical regression. A revision of the amyloid problem. Zentralbl Allg Pathol 119(6):533-548
-
(1975)
Zentralbl Allg Pathol
, vol.119
, Issue.6
, pp. 533-548
-
-
Schwartz, P.1
-
6
-
-
0017284828
-
Neurofibrillary tangles of paired helical filaments
-
Wisniewski HM, Narang HK, Terry RD (1976) Neurofibrillary tangles of paired helical filaments. J Neurol Sci 27(2):173-181
-
(1976)
J Neurol Sci
, vol.27
, Issue.2
, pp. 173-181
-
-
Wisniewski, H.M.1
Narang, H.K.2
Terry, R.D.3
-
7
-
-
0013859362
-
Correlation between scores for dementia and counts of 'senile plaques' in cerebral grey matter of elderly subjects
-
Roth M, Tomlinson BE, Blessed G (1966) Correlation between scores for dementia and counts of 'senile plaques' in cerebral grey matter of elderly subjects. Nature 209(18):109-110
-
(1966)
Nature
, vol.209
, Issue.18
, pp. 109-110
-
-
Roth, M.1
Tomlinson, B.E.2
Blessed, G.3
-
8
-
-
0014059993
-
The relationship between quantitative measures of dementia and of degenerative changes in the cerebral grey matter of elderly subjects
-
Roth M, Tomlinson BE, Blessed G (1967) The relationship between quantitative measures of dementia and of degenerative changes in the cerebral grey matter of elderly subjects. Proc R Soc Med 60(3):254-260
-
(1967)
Proc R Soc Med
, vol.60
, Issue.3
, pp. 254-260
-
-
Roth, M.1
Tomlinson, B.E.2
Blessed, G.3
-
9
-
-
0014313861
-
The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects
-
Blessed G, Tomlinson BE, Roth M (1968) The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 114(512):797-811
-
(1968)
Br J Psychiatry
, vol.114
, Issue.512
, pp. 797-811
-
-
Blessed, G.1
Tomlinson, B.E.2
Roth, M.3
-
10
-
-
0020610178
-
The dementia patient: Evaluation and care
-
Rabins PV, Folstein MF (1983) The dementia patient: evaluation and care. Geriatrics 38(8):99-103
-
(1983)
Geriatrics
, vol.38
, Issue.8
, pp. 99-103
-
-
Rabins, P.V.1
Folstein, M.F.2
-
11
-
-
0022002826
-
Cerebrospinal fluid acetylcholinesterase activity in senile dementia of the Alzheimer type
-
Tune L, Gucker S, Folstein M, Oshida L, Coyle JT (1985) Cerebrospinal fluid acetylcholinesterase activity in senile dementia of the Alzheimer type. Ann Neurol 17(1):46-48
-
(1985)
Ann Neurol
, vol.17
, Issue.1
, pp. 46-48
-
-
Tune, L.1
Gucker, S.2
Folstein, M.3
Oshida, L.4
Coyle, J.T.5
-
12
-
-
0022643740
-
Cerebral ventricular size and cerebrospinal fluid acetylcholinesterase levels in senile dementia of the Alzheimer type
-
Pearlson GD, Tune LE (1986) Cerebral ventricular size and cerebrospinal fluid acetylcholinesterase levels in senile dementia of the Alzheimer type. Psychiatry Res 17(1):23-29
-
(1986)
Psychiatry Res
, vol.17
, Issue.1
, pp. 23-29
-
-
Pearlson, G.D.1
Tune, L.E.2
-
13
-
-
0023067523
-
Comparison of two cognitive rating scales in medically ill patients
-
Burch EA Jr, Andrews SR (1987) Comparison of two cognitive rating scales in medically ill patients. Int J Psychiatry Med 17(2):193-200
-
(1987)
Int J Psychiatry Med
, vol.17
, Issue.2
, pp. 193-200
-
-
Burch Jr, E.A.1
Andrews, S.R.2
-
14
-
-
0000748464
-
Experimental production of neurofibrillary degeneration 1, light microscopic observations
-
Klatzo I, Wisniewski H, Streicher E (1965) Experimental production of neurofibrillary degeneration 1, light microscopic observations. J Neuropathol Exp Neurol 24:187-199
-
(1965)
J Neuropathol Exp Neurol
, vol.24
, pp. 187-199
-
-
Klatzo, I.1
Wisniewski, H.2
Streicher, E.3
-
15
-
-
0000748465
-
Experimental production of neurofibrillary degeneration 2, electron microscopy, phosphatase histochemistry and electron probe analysis
-
Terry RD, Pena C (1965) Experimental production of neurofibrillary degeneration 2, electron microscopy, phosphatase histochemistry and electron probe analysis. J Neuropathol Exp Neurol 24:200-210
-
(1965)
J Neuropathol Exp Neurol
, vol.24
, pp. 200-210
-
-
Terry, R.D.1
Pena, C.2
-
16
-
-
0015870305
-
Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration
-
Crapper DR, Krishnan SS, Dalton AJ (1973) Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration. Trans Am Neurol Assoc 98:17-20
-
(1973)
Trans Am Neurol Assoc
, vol.98
, pp. 17-20
-
-
Crapper, D.R.1
Krishnan, S.S.2
Dalton, A.J.3
-
17
-
-
0015913994
-
Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration
-
Crapper DR, Krishnan SS, Dalton AJ (1973) Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration. Science 180(85):511-513
-
(1973)
Science
, vol.180
, Issue.85
, pp. 511-513
-
-
Crapper, D.R.1
Krishnan, S.S.2
Dalton, A.J.3
-
18
-
-
0017260845
-
Aluminium, neurofibrillary degeneration and Alzheimer's disease
-
Crapper DR, Krishnan SS, Quittkat S (1976) Aluminium, neurofibrillary degeneration and Alzheimer's disease. Brain 99(1):67-80
-
(1976)
Brain
, vol.99
, Issue.1
, pp. 67-80
-
-
Crapper, D.R.1
Krishnan, S.S.2
Quittkat, S.3
-
19
-
-
0020859611
-
Relationship between nutrition and dementia in the elderly
-
Vatassery GT, Maletta GJ (1983) Relationship between nutrition and dementia in the elderly. Psychiatr Med 1(4):429-443
-
(1983)
Psychiatr Med
, vol.1
, Issue.4
, pp. 429-443
-
-
Vatassery, G.T.1
Maletta, G.J.2
-
20
-
-
0011162190
-
Selective loss of central cholinergic neurons in Alzheimer's disease
-
Davies P, Maloney AJ (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2(8000):1403
-
(1976)
Lancet
, vol.2
, Issue.8000
, pp. 1403
-
-
Davies, P.1
Maloney, A.J.2
-
21
-
-
0033018477
-
Acetylcholine in mind: A neurotransmitter correlate of consciousness?
-
Perry E, Walker M, Grace J, Perry R (1999) Acetylcholine in mind: a neurotransmitter correlate of consciousness?. Trends Neurosci 22:273-280
-
(1999)
Trends Neurosci
, vol.22
, pp. 273-280
-
-
Perry, E.1
Walker, M.2
Grace, J.3
Perry, R.4
-
22
-
-
0019410162
-
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
-
Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR (1981) Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10(2):122-126
-
(1981)
Ann Neurol
, vol.10
, Issue.2
, pp. 122-126
-
-
Whitehouse, P.J.1
Price, D.L.2
Clark, A.W.3
Coyle, J.T.4
DeLong, M.R.5
-
23
-
-
33644660826
-
Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A beta antibody
-
Bales KR, Tzavara ET, Wu S, Wade MR, Bymaster FP, Paul SM, Nomikos GG (2006) Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A beta antibody. J Clin Invest 116(3):825-832
-
(2006)
J Clin Invest
, vol.116
, Issue.3
, pp. 825-832
-
-
Bales, K.R.1
Tzavara, E.T.2
Wu, S.3
Wade, M.R.4
Bymaster, F.P.5
Paul, S.M.6
Nomikos, G.G.7
-
24
-
-
0025724980
-
Clinical issues of cognitive enhancers in Alzheimer disease
-
Calvani M, Carta A (1991) Clinical issues of cognitive enhancers in Alzheimer disease. Alzheimer Dis Assoc Disord 5(S1):25-31
-
(1991)
Alzheimer Dis Assoc Disord
, vol.5
, Issue.S1
, pp. 25-31
-
-
Calvani, M.1
Carta, A.2
-
25
-
-
0021249811
-
Immunoglobulin and other proteins in the cerebrospinal fluid of patients with Alzheimer's disease
-
Chapel HM, Esiri MM, Wilcock GK (1984) Immunoglobulin and other proteins in the cerebrospinal fluid of patients with Alzheimer's disease. J Clin Pathol 37(6):697-699
-
(1984)
J Clin Pathol
, vol.37
, Issue.6
, pp. 697-699
-
-
Chapel, H.M.1
Esiri, M.M.2
Wilcock, G.K.3
-
26
-
-
0022457104
-
A neuronal antigen in the brains of Alzheimer patients
-
Wolozin BL, Pruchnicki A, Dickson DW, Davies P (1986) A neuronal antigen in the brains of Alzheimer patients. Science 232(4750):648-650
-
(1986)
Science
, vol.232
, Issue.4750
, pp. 648-650
-
-
Wolozin, B.L.1
Pruchnicki, A.2
Dickson, D.W.3
Davies, P.4
-
27
-
-
0028277520
-
Identification of two distinct synucleins from human brain
-
Jakes R, Spillantini MG, Goedert M (1994) Identification of two distinct synucleins from human brain. FEBS Lett 345(1):27-32
-
(1994)
FEBS Lett
, vol.345
, Issue.1
, pp. 27-32
-
-
Jakes, R.1
Spillantini, M.G.2
Goedert, M.3
-
28
-
-
0036150827
-
Alzheimer's disease-do tauists and baptists finally shake hands?
-
Mudher A, Lovestone S (2002) Alzheimer's disease-do tauists and baptists finally shake hands? Trends Neurosci 25(1):22-26
-
(2002)
Trends Neurosci
, vol.25
, Issue.1
, pp. 22-26
-
-
Mudher, A.1
Lovestone, S.2
-
29
-
-
0036713259
-
Tauists, Baptists, Syners, Apostates, and new data
-
Trojanowski JQ (2002) Tauists, Baptists, Syners, Apostates, and new data. Ann Neurol 52(3):263-265
-
(2002)
Ann Neurol
, vol.52
, Issue.3
, pp. 263-265
-
-
Trojanowski, J.Q.1
-
30
-
-
0025600931
-
Diffuse plaques do not accentuate synapse loss in Alzheimer's disease
-
Masliah E, Terry RD, Mallory M, Alford M, Hansen LA (1990) Diffuse plaques do not accentuate synapse loss in Alzheimer's disease. Am J Pathol 137(6):1293-1297
-
(1990)
Am J Pathol
, vol.137
, Issue.6
, pp. 1293-1297
-
-
Masliah, E.1
Terry, R.D.2
Mallory, M.3
Alford, M.4
Hansen, L.A.5
-
31
-
-
0344845129
-
Pathology of presynaptic proteins in Alzheimer's disease: More than simple loss of terminals
-
Honer WG (2003) Pathology of presynaptic proteins in Alzheimer's disease: more than simple loss of terminals. Neurobiol Aging 24(8):1047-1062
-
(2003)
Neurobiol Aging
, vol.24
, Issue.8
, pp. 1047-1062
-
-
Honer, W.G.1
-
32
-
-
0030928406
-
Beta-Amyloid-associated free radical oxidative stress and neurotoxicity: Implications for Alzheimer's disease
-
Butterfield DA (1997) Beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease. Chem Res Toxicol 10(5):495-506
-
(1997)
Chem Res Toxicol
, vol.10
, Issue.5
, pp. 495-506
-
-
Butterfield, D.A.1
-
33
-
-
0030921729
-
Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: Relevance to Alzheimer's disease
-
Butterfield DA, Hensley K, Cole P, Subramaniam R, Aksenov M, Aksenova M, Bummer PM, Haley BE, Carney JM (1997) Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer's disease. J Neurochem 68(6):2451-2457
-
(1997)
J Neurochem
, vol.68
, Issue.6
, pp. 2451-2457
-
-
Butterfield, D.A.1
Hensley, K.2
Cole, P.3
Subramaniam, R.4
Aksenov, M.5
Aksenova, M.6
Bummer, P.M.7
Haley, B.E.8
Carney, J.M.9
-
34
-
-
0030746621
-
The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins
-
Subramaniam R, Roediger F, Jordan B, Mattson MP, Keller JN, Waeg G, Butterfield DA (1997) The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins. J Neurochem 69(3):1161-1169
-
(1997)
J Neurochem
, vol.69
, Issue.3
, pp. 1161-1169
-
-
Subramaniam, R.1
Roediger, F.2
Jordan, B.3
Mattson, M.P.4
Keller, J.N.5
Waeg, G.6
Butterfield, D.A.7
-
35
-
-
0032948006
-
Peroxynitrite-induced alterations in synaptosomal membrane proteins: Insight into oxidative stress in Alzheimer's disease
-
Koppal T, Drake J, Yatin S, Jordan B, Varadarajan S, Bettenhausen L, Butterfield DA (1999) Peroxynitrite-induced alterations in synaptosomal membrane proteins: insight into oxidative stress in Alzheimer's disease. J Neurochem 72(1):310-317
-
(1999)
J Neurochem
, vol.72
, Issue.1
, pp. 310-317
-
-
Koppal, T.1
Drake, J.2
Yatin, S.3
Jordan, B.4
Varadarajan, S.5
Bettenhausen, L.6
Butterfield, D.A.7
-
37
-
-
0022620652
-
Vitamin E in brains of patients with Alzheimer's disease and Down's syndrome
-
Muller DP, Metcalfe T, Bowen DM (1986) Vitamin E in brains of patients with Alzheimer's disease and Down's syndrome. Lancet 1(8489):1093-1094
-
(1986)
Lancet 1
, vol.8489
, pp. 1093-1094
-
-
Muller, D.P.1
Metcalfe, T.2
Bowen, D.M.3
-
38
-
-
0024801532
-
Vitamin E concentrations in human brain of patients with Alzheimer's disease, fetuses with Down's syndrome, centenarians, and controls
-
Metcalfe T, Bowen DM, Muller DP (1989) Vitamin E concentrations in human brain of patients with Alzheimer's disease, fetuses with Down's syndrome, centenarians, and controls. Neurochem Res 14(12):1209-1212
-
(1989)
Neurochem Res
, vol.14
, Issue.12
, pp. 1209-1212
-
-
Metcalfe, T.1
Bowen, D.M.2
Muller, D.P.3
-
39
-
-
0026547646
-
Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease
-
Zaman Z, Roche S, Fielden P, Frost PG, Niriella DC, Cayley AC (1992) Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease. Age Ageing 21(2):91-94
-
(1992)
Age Ageing
, vol.21
, Issue.2
, pp. 91-94
-
-
Zaman, Z.1
Roche, S.2
Fielden, P.3
Frost, P.G.4
Niriella, D.C.5
Cayley, A.C.6
-
40
-
-
0028177379
-
Concentrations of alpha-tocopherol and its quinone derivative in cerebrospinal fluid from patients with vascular dementia of the Binswanger type and Alzheimer type dementia
-
Tohgi H, Abe T, Nakanishi M, Hamato F, Sasaki K, Takahashi S (1994) Concentrations of alpha-tocopherol and its quinone derivative in cerebrospinal fluid from patients with vascular dementia of the Binswanger type and Alzheimer type dementia. Neurosci Lett 174(1):73-76
-
(1994)
Neurosci Lett
, vol.174
, Issue.1
, pp. 73-76
-
-
Tohgi, H.1
Abe, T.2
Nakanishi, M.3
Hamato, F.4
Sasaki, K.5
Takahashi, S.6
-
41
-
-
9844235930
-
Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease
-
Jimenez-Jimenez FJ, de Bustos F, Molina JA, Benito-Leon J, Tallon-Barranco A, Gasalla T, Orti-Pareja M, Guillamon F, Rubio JC, Arenas J, Enriquez-de-Salamanca R (1997) Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease. J Neural Transm 104(6-7):703-710
-
(1997)
J Neural Transm
, vol.104
, Issue.6-7
, pp. 703-710
-
-
Jimenez-Jimenez, F.J.1
de Bustos, F.2
Molina, J.A.3
Benito-Leon, J.4
Tallon-Barranco, A.5
Gasalla, T.6
Orti-Pareja, M.7
Guillamon, F.8
Rubio, J.C.9
Arenas, J.10
Enriquez-de-Salamanca, R.11
-
42
-
-
0030967165
-
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease
-
Sano M, Ernesto C, Thomas RG et al (1997) A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med 336:1216-1222
-
(1997)
N Engl J Med
, vol.336
, pp. 1216-1222
-
-
Sano, M.1
Ernesto, C.2
Thomas, R.G.3
-
43
-
-
20344381835
-
Vitamin E and donepezil for the treatment of mild cognitive impairment
-
Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ (2005) Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 352(23):2379-2388
-
(2005)
N Engl J Med
, vol.352
, Issue.23
, pp. 2379-2388
-
-
Petersen, R.C.1
Thomas, R.G.2
Grundman, M.3
Bennett, D.4
Doody, R.5
Ferris, S.6
Galasko, D.7
Jin, S.8
Kaye, J.9
Levey, A.10
Pfeiffer, E.11
Sano, M.12
van Dyck, C.H.13
Thal, L.J.14
-
44
-
-
28544453282
-
Dementia and Alzheimer's disease in community-dwelling elders taking vitamin C and/or vitamin E
-
Fillenbaum GG, Kuchibhatla MN, Hanlon JT, Artz MB, Pieper CF, Schmader KE, Dysken MW, Gray SL (2005) Dementia and Alzheimer's disease in community-dwelling elders taking vitamin C and/or vitamin E. Ann Pharmacother 39(12):2009-2014
-
(2005)
Ann Pharmacother
, vol.39
, Issue.12
, pp. 2009-2014
-
-
Fillenbaum, G.G.1
Kuchibhatla, M.N.2
Hanlon, J.T.3
Artz, M.B.4
Pieper, C.F.5
Schmader, K.E.6
Dysken, M.W.7
Gray, S.L.8
-
45
-
-
0026500120
-
Alzheimers disease: A 'cobalaminergic' hypothesis
-
McCaddon A, Kelly CL (1992) Alzheimers disease: a 'cobalaminergic' hypothesis. Med Hypotheses 37:161-165
-
(1992)
Med Hypotheses
, vol.37
, pp. 161-165
-
-
McCaddon, A.1
Kelly, C.L.2
-
46
-
-
0021194210
-
Low serum vitamin B12 in Alzheimer-type dementia
-
Cole MG, Prchal JF (1984) Low serum vitamin B12 in Alzheimer-type dementia. Age Ageing 13(2):101-105
-
(1984)
Age Ageing
, vol.13
, Issue.2
, pp. 101-105
-
-
Cole, M.G.1
Prchal, J.F.2
-
47
-
-
0025197214
-
Vitamin B12 levels in serum and cerebrospinal fluid of people with Alzheimer's disease
-
Ikeda T, Furukawa Y, Mashimoto S, Takahashi K, Yamada M (1990) Vitamin B12 levels in serum and cerebrospinal fluid of people with Alzheimer's disease. Acta Psychiatr Scand 82(4):327-329
-
(1990)
Acta Psychiatr Scand
, vol.82
, Issue.4
, pp. 327-329
-
-
Ikeda, T.1
Furukawa, Y.2
Mashimoto, S.3
Takahashi, K.4
Yamada, M.5
-
49
-
-
0036523032
-
Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease
-
Kruman II, Kumaravel TS, Lohani A, Pedersen WA, Cutler RG, Kruman Y, Haughey N, Lee J, Evans M, Mattson MP (2002) Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 22(5):1752-1762
-
(2002)
J Neurosci
, vol.22
, Issue.5
, pp. 1752-1762
-
-
Kruman, I.I.1
Kumaravel, T.S.2
Lohani, A.3
Pedersen, W.A.4
Cutler, R.G.5
Kruman, Y.6
Haughey, N.7
Lee, J.8
Evans, M.9
Mattson, M.P.10
-
50
-
-
0026600591
-
Slowed synthesis of DNA and methionine is a pathogenetic mechanism common to dementia in Down's syndrome, AIDS and Alzheimer's disease?
-
Regland B, Gottfries CG (1992) Slowed synthesis of DNA and methionine is a pathogenetic mechanism common to dementia in Down's syndrome, AIDS and Alzheimer's disease?. Med Hypotheses 38(1):11-19
-
(1992)
Med Hypotheses
, vol.38
, Issue.1
, pp. 11-19
-
-
Regland, B.1
Gottfries, C.G.2
-
51
-
-
0034103586
-
Inherent abnormalities in energy metabolism in Alzheimer disease. Interaction with cerebrovascular compromise
-
Blass JP, Sheu RK, Gibson GE (2000) Inherent abnormalities in energy metabolism in Alzheimer disease. Interaction with cerebrovascular compromise. Ann N Y Acad Sci 903:204-221
-
(2000)
Ann N Y Acad Sci
, vol.903
, pp. 204-221
-
-
Blass, J.P.1
Sheu, R.K.2
Gibson, G.E.3
-
52
-
-
18244390483
-
Mitochondrial abnormalities in Alzheimer brain: Mechanistic implications
-
Bubber P, Haroutunian V, Fisch G, Blass JP, Gibson GE (2005) Mitochondrial abnormalities in Alzheimer brain: mechanistic implications. Ann Neurol 57(5):695-703
-
(2005)
Ann Neurol
, vol.57
, Issue.5
, pp. 695-703
-
-
Bubber, P.1
Haroutunian, V.2
Fisch, G.3
Blass, J.P.4
Gibson, G.E.5
-
53
-
-
0036788005
-
Is Alzheimer's disease a mitochondrial disorder?
-
Cash AD, Perry G, Ogawa O, Raina AK, Zhu X, Smith MA (2002) Is Alzheimer's disease a mitochondrial disorder? Neuroscientist 8(5):489-496
-
(2002)
Neuroscientist
, vol.8
, Issue.5
, pp. 489-496
-
-
Cash, A.D.1
Perry, G.2
Ogawa, O.3
Raina, A.K.4
Zhu, X.5
Smith, M.A.6
-
54
-
-
0031737226
-
Abnormalities of mitochondrial enzymes in Alzheimer disease
-
Gibson GE, Sheu KF, Blass JP (1998) Abnormalities of mitochondrial enzymes in Alzheimer disease. J Neural Transm 105(8-9):855-870
-
(1998)
J Neural Transm
, vol.105
, Issue.8-9
, pp. 855-870
-
-
Gibson, G.E.1
Sheu, K.F.2
Blass, J.P.3
-
55
-
-
0033990449
-
The alpha-ketoglutarate dehydrogenase complex in neurodegeneration
-
Gibson GE, Park LC, Sheu KF, Blass JP, Calingasan NY (2000) The alpha-ketoglutarate dehydrogenase complex in neurodegeneration. Neurochem Int 36(2):97-112
-
(2000)
Neurochem Int
, vol.36
, Issue.2
, pp. 97-112
-
-
Gibson, G.E.1
Park, L.C.2
Sheu, K.F.3
Blass, J.P.4
Calingasan, N.Y.5
-
56
-
-
0029044160
-
Carnitine, carnitine acetyltransferase, and glutathione in Alzheimer brain
-
Makar TK, Cooper AJ, Tofel-Grehl B, Thaler HT, Blass JP (1995) Carnitine, carnitine acetyltransferase, and glutathione in Alzheimer brain. Neurochem Res 20(6):705-711
-
(1995)
Neurochem Res
, vol.20
, Issue.6
, pp. 705-711
-
-
Makar, T.K.1
Cooper, A.J.2
Tofel-Grehl, B.3
Thaler, H.T.4
Blass, J.P.5
-
57
-
-
0024786493
-
Double-blind, placebo controlled study of acetyl-1-carnitine in patients with Alzheimer's dementia
-
Rai G, Wright G, Scott L, Beston B, Rest J, Exton-Smith AN (1990) Double-blind, placebo controlled study of acetyl-1-carnitine in patients with Alzheimer's dementia. Curr Med Res Opin 11(10):638-647
-
(1990)
Curr Med Res Opin
, vol.11
, Issue.10
, pp. 638-647
-
-
Rai, G.1
Wright, G.2
Scott, L.3
Beston, B.4
Rest, J.5
Exton-Smith, A.N.6
-
58
-
-
0025163429
-
Acetyl-L-carnitine in the treatment of mildly demented elderly patients
-
Passeri M, Cucinotta D, Bonati PA, Iannuccelli M, Parnetti L, Senin U (1990) Acetyl-L-carnitine in the treatment of mildly demented elderly patients. Int J Clin Pharmacol Res 10(1-2):75-79
-
(1990)
Int J Clin Pharmacol Res
, vol.10
, Issue.1-2
, pp. 75-79
-
-
Passeri, M.1
Cucinotta, D.2
Bonati, P.A.3
Iannuccelli, M.4
Parnetti, L.5
Senin, U.6
-
59
-
-
0026403940
-
Acetyl-L-carnitine: A drug able to slow the progress of Alzheimer's disease?
-
Carta A, Calvani M (1991) Acetyl-L-carnitine: a drug able to slow the progress of Alzheimer's disease? Ann N Y Acad Sci 640:228-232
-
(1991)
Ann N Y Acad Sci
, vol.640
, pp. 228-232
-
-
Carta, A.1
Calvani, M.2
-
60
-
-
0026002366
-
Long-term acetyl-L-carnitine treatment in Alzheimer's disease
-
Spagnoli A, Lucca U, Menasce G, Bandiera L, Cizza G, Forloni G, Tettamanti M, Frattura L, Tiraboschi P, Pomelli M et al (1991) Long-term acetyl-L-carnitine treatment in Alzheimer's disease. Neurology 41(11):1726-1732
-
(1991)
Neurology
, vol.41
, Issue.11
, pp. 1726-1732
-
-
Spagnoli, A.1
Lucca, U.2
Menasce, G.3
Bandiera, L.4
Cizza, G.5
Forloni, G.6
Tettamanti, M.7
Frattura, L.8
Tiraboschi, P.9
Pomelli, M.10
-
61
-
-
0026460074
-
Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease
-
Sano M, Bell K, Cote L, Dooneief G, Lawton A, Legler L, Marder K, Naini A, Stern Y, Mayeux R (1992) Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease. Arch Neurol 49(11):1137-1141
-
(1992)
Arch Neurol
, vol.49
, Issue.11
, pp. 1137-1141
-
-
Sano, M.1
Bell, K.2
Cote, L.3
Dooneief, G.4
Lawton, A.5
Legler, L.6
Marder, K.7
Naini, A.8
Stern, Y.9
Mayeux, R.10
-
62
-
-
0027374505
-
Acetyl-L- carnitine and Alzheimer's disease: Pharmacological considerations beyond the cholinergic sphere
-
Carta A, Calvani M, Bravi D, Bhuachalla SN (1993) Acetyl-L- carnitine and Alzheimer's disease: pharmacological considerations beyond the cholinergic sphere. Ann N Y Acad Sci 695:324-326
-
(1993)
Ann N Y Acad Sci
, vol.695
, pp. 324-326
-
-
Carta, A.1
Calvani, M.2
Bravi, D.3
Bhuachalla, S.N.4
-
63
-
-
0034718466
-
A 1-year controlled trial of acetyl-l-carnitine in early-onset AD
-
Thal LJ, Calvani M, Amato A, Carta A (2000) A 1-year controlled trial of acetyl-l-carnitine in early-onset AD. Neurology 55(6):805-810
-
(2000)
Neurology
, vol.55
, Issue.6
, pp. 805-810
-
-
Thal, L.J.1
Calvani, M.2
Amato, A.3
Carta, A.4
-
64
-
-
0037347231
-
Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease
-
Montgomery SA, Thal LJ, Amrein R (2003) Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. Int Clin Psychopharmacol 18(2):61-71
-
(2003)
Int Clin Psychopharmacol
, vol.18
, Issue.2
, pp. 61-71
-
-
Montgomery, S.A.1
Thal, L.J.2
Amrein, R.3
-
65
-
-
0033848159
-
Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype
-
Gibson GE, Haroutunian V, Zhang H, Park LC, Shi Q, Lesser M, Mohs RC, Sheu RK, Blass JP (2000) Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype. Ann Neurol 48(3):297-303
-
(2000)
Ann Neurol
, vol.48
, Issue.3
, pp. 297-303
-
-
Gibson, G.E.1
Haroutunian, V.2
Zhang, H.3
Park, L.C.4
Shi, Q.5
Lesser, M.6
Mohs, R.C.7
Sheu, R.K.8
Blass, J.P.9
-
66
-
-
0027407565
-
Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
-
Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90(5):1977-1981
-
(1993)
Proc Natl Acad Sci USA
, vol.90
, Issue.5
, pp. 1977-1981
-
-
Strittmatter, W.J.1
Saunders, A.M.2
Schmechel, D.3
Pericak-Vance, M.4
Enghild, J.5
Salvesen, G.S.6
Roses, A.D.7
-
67
-
-
12044254746
-
-
Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD (1993) Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 90(17):8098-8102
-
Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD (1993) Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 90(17):8098-8102
-
-
-
-
68
-
-
0029743646
-
Apolipoprotein E in neurology
-
Roses AD (1996) Apolipoprotein E in neurology. Curr Opin Neurol 9(4):265-270
-
(1996)
Curr Opin Neurol
, vol.9
, Issue.4
, pp. 265-270
-
-
Roses, A.D.1
-
69
-
-
0021847779
-
High-density lipoprotein cholesterol in differential diagnosis of senile dementia
-
Muckle TJ, Roy JR (1985) High-density lipoprotein cholesterol in differential diagnosis of senile dementia. Lancet 1(8439):1191-1193
-
(1985)
Lancet 1
, vol.8439
, pp. 1191-1193
-
-
Muckle, T.J.1
Roy, J.R.2
-
70
-
-
27844458139
-
Insulin and cholesterol pathways in neuronal function, memory and neurodegeneration
-
Nelson TJ, Alkon DL (2005) Insulin and cholesterol pathways in neuronal function, memory and neurodegeneration. Biochem Soc Trans 33(5):1033-1036
-
(2005)
Biochem Soc Trans
, vol.33
, Issue.5
, pp. 1033-1036
-
-
Nelson, T.J.1
Alkon, D.L.2
-
71
-
-
23744487059
-
Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease
-
Lane RM, Farlow MR (2005) Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease. J Lipid Res 46(5):949-968
-
(2005)
J Lipid Res
, vol.46
, Issue.5
, pp. 949-968
-
-
Lane, R.M.1
Farlow, M.R.2
-
72
-
-
0015822555
-
A critical review of brain cholesterol metabolism
-
Kabara JJ (1973) A critical review of brain cholesterol metabolism. Prog Brain Res 40:363-382
-
(1973)
Prog Brain Res
, vol.40
, pp. 363-382
-
-
Kabara, J.J.1
-
73
-
-
0036736781
-
Do oxysterols control cholesterol homeostasis?
-
Bjorkhem I (2002) Do oxysterols control cholesterol homeostasis? J Clin Invest 110(6):725-730
-
(2002)
J Clin Invest
, vol.110
, Issue.6
, pp. 725-730
-
-
Bjorkhem, I.1
-
74
-
-
2442557294
-
Brain cholesterol: Long secret life behind a barrier
-
Bjorkhem I, Meaney S (2004) Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol 24(5):806-815
-
(2004)
Arterioscler Thromb Vasc Biol
, vol.24
, Issue.5
, pp. 806-815
-
-
Bjorkhem, I.1
Meaney, S.2
-
75
-
-
33947611668
-
Isolation, constitution and biological significance of cerebrosterol, a companion of cholesterol in the horse brain
-
Ercoli A, Di Frisco S, De Ruggeri P (1953) Isolation, constitution and biological significance of cerebrosterol, a companion of cholesterol in the horse brain. Boll Soc Ital Biol Sper 29(4):494-497
-
(1953)
Boll Soc Ital Biol Sper
, vol.29
, Issue.4
, pp. 494-497
-
-
Ercoli, A.1
Di Frisco, S.2
De Ruggeri, P.3
-
77
-
-
0015804396
-
Biosynthesis of cholest-5-ene-3beta, 24-diol (cerebrosterol) by bovine cerebral cortical microsomes
-
Dhar AK, Teng JI, Smith LL (1973) Biosynthesis of cholest-5-ene-3beta, 24-diol (cerebrosterol) by bovine cerebral cortical microsomes. J Neurochem 21(1):51-60
-
(1973)
J Neurochem
, vol.21
, Issue.1
, pp. 51-60
-
-
Dhar, A.K.1
Teng, J.I.2
Smith, L.L.3
-
78
-
-
0029835410
-
Cholesterol homeostasis in human brain: Evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation
-
Lutjohann D, Breuer O, Ahlborg G, Nennesmo I, Siden A, Diczfalusy U, Bjorkhem I (1996) Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci USA 93(18):9799-9804
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, Issue.18
, pp. 9799-9804
-
-
Lutjohann, D.1
Breuer, O.2
Ahlborg, G.3
Nennesmo, I.4
Siden, A.5
Diczfalusy, U.6
Bjorkhem, I.7
-
79
-
-
0004821712
-
Plasma 24S- hydroxycholesterol: A peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease
-
Papassotiropoulos A, Lutjohann D, Bagli M, Locatelli S, Jessen F, Rao ML, Maier W, Bjorkhem I, von Bergmann K, Heun R (2000) Plasma 24S- hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease. Neuroreport 11(9):1959-1962
-
(2000)
Neuroreport
, vol.11
, Issue.9
, pp. 1959-1962
-
-
Papassotiropoulos, A.1
Lutjohann, D.2
Bagli, M.3
Locatelli, S.4
Jessen, F.5
Rao, M.L.6
Maier, W.7
Bjorkhem, I.8
von Bergmann, K.9
Heun, R.10
-
80
-
-
0343775806
-
Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients
-
Lutjohann D, Papassotiropoulos A, Bjorkhem I, Locatelli S, Bagli M, Oehring RD, Schlegel U, Jessen F, Rao ML, von Bergmann K, Heun R (2000) Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J Lipid Res 41(2):195-198
-
(2000)
J Lipid Res
, vol.41
, Issue.2
, pp. 195-198
-
-
Lutjohann, D.1
Papassotiropoulos, A.2
Bjorkhem, I.3
Locatelli, S.4
Bagli, M.5
Oehring, R.D.6
Schlegel, U.7
Jessen, F.8
Rao, M.L.9
von Bergmann, K.10
Heun, R.11
-
81
-
-
21344469049
-
24S-hydroxycholesterol induces inflammatory gene expression in primary human neural cells
-
Alexandrov P, Cui JG, Zhao Y, Lukiw WJ (2005) 24S-hydroxycholesterol induces inflammatory gene expression in primary human neural cells. Neuroreport 16(9):909-913
-
(2005)
Neuroreport
, vol.16
, Issue.9
, pp. 909-913
-
-
Alexandrov, P.1
Cui, J.G.2
Zhao, Y.3
Lukiw, W.J.4
-
82
-
-
0034904940
-
Neurotoxicity of 24-hydroxycholesterol, an important cholesterol elimination product of the brain, may be prevented by vitamin E and estradiol-17beta
-
Kolsch H, Ludwig M, Lutjohann D, Rao ML (2001) Neurotoxicity of 24-hydroxycholesterol, an important cholesterol elimination product of the brain, may be prevented by vitamin E and estradiol-17beta. J Neural Transm 108(4):475-488
-
(2001)
J Neural Transm
, vol.108
, Issue.4
, pp. 475-488
-
-
Kolsch, H.1
Ludwig, M.2
Lutjohann, D.3
Rao, M.L.4
-
83
-
-
0842303768
-
Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease
-
Heverin M, Bogdanovic N, Lutjohann D, Bayer T, Pikuleva I, Bretillon L, Diczfalusy U, Winblad B, Bjorkhem I (2004) Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. J Lipid Res 45(1):186-193
-
(2004)
J Lipid Res
, vol.45
, Issue.1
, pp. 186-193
-
-
Heverin, M.1
Bogdanovic, N.2
Lutjohann, D.3
Bayer, T.4
Pikuleva, I.5
Bretillon, L.6
Diczfalusy, U.7
Winblad, B.8
Bjorkhem, I.9
-
84
-
-
0022350033
-
Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system
-
Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM (1985) Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 76(4):1501-1513
-
(1985)
J Clin Invest
, vol.76
, Issue.4
, pp. 1501-1513
-
-
Boyles, J.K.1
Pitas, R.E.2
Wilson, E.3
Mahley, R.W.4
Taylor, J.M.5
-
85
-
-
0023280054
-
Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain
-
Pitas RE, Boyles JK, Lee SH, Hui D, Weisgraber KH (1987) Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J Biol Chem 262(29):14352-14360
-
(1987)
J Biol Chem
, vol.262
, Issue.29
, pp. 14352-14360
-
-
Pitas, R.E.1
Boyles, J.K.2
Lee, S.H.3
Hui, D.4
Weisgraber, K.H.5
-
86
-
-
0024574009
-
A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve
-
Boyles JK, Zoellner CD, Anderson LJ, Kosik LM, Pitas RE, Weisgraber KH, Hui DY, Mahley RW, Gebicke-Haerter PJ, Ignatius MJ et al (1989) A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest 83(3):1015-1031
-
(1989)
J Clin Invest
, vol.83
, Issue.3
, pp. 1015-1031
-
-
Boyles, J.K.1
Zoellner, C.D.2
Anderson, L.J.3
Kosik, L.M.4
Pitas, R.E.5
Weisgraber, K.H.6
Hui, D.Y.7
Mahley, R.W.8
Gebicke-Haerter, P.J.9
Ignatius, M.J.10
-
87
-
-
0035836436
-
Neuronal injury-induced expression and release of apolipoprotein E in mixed neuron/glia co-cultures: Nuclear factor kappaB inhibitors reduce basal and lesion-induced secretion of apolipoprotein E
-
Petegnief V, Saura J, de Gregorio-Rocasolano N, Paul SM (2001) Neuronal injury-induced expression and release of apolipoprotein E in mixed neuron/glia co-cultures: nuclear factor kappaB inhibitors reduce basal and lesion-induced secretion of apolipoprotein E. Neuroscience 104(1):223-2334
-
(2001)
Neuroscience
, vol.104
, Issue.1
, pp. 223-2334
-
-
Petegnief, V.1
Saura, J.2
de Gregorio-Rocasolano, N.3
Paul, S.M.4
-
88
-
-
33645299023
-
The involvement of lipid rafts in Alzheimer's disease
-
Cordy JM, Hooper NM, Turner AJ (2006) The involvement of lipid rafts in Alzheimer's disease. Mol Membr Biol 23(1):111-122
-
(2006)
Mol Membr Biol
, vol.23
, Issue.1
, pp. 111-122
-
-
Cordy, J.M.1
Hooper, N.M.2
Turner, A.J.3
-
89
-
-
12444340438
-
Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology
-
Pappolla MA, Bryant-Thomas TK, Herbert D, Pacheco J, Fabra Garcia M, Manjon M, Girones X, Henry TL, Matsubara E, Zambon D, Wolozin B, Sano M, Cruz-Sanchez FF, Thal LJ, Petanceska SS, Refolo LM (2003) Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology 61(2):199-205
-
(2003)
Neurology
, vol.61
, Issue.2
, pp. 199-205
-
-
Pappolla, M.A.1
Bryant-Thomas, T.K.2
Herbert, D.3
Pacheco, J.4
Fabra Garcia, M.5
Manjon, M.6
Girones, X.7
Henry, T.L.8
Matsubara, E.9
Zambon, D.10
Wolozin, B.11
Sano, M.12
Cruz-Sanchez, F.F.13
Thal, L.J.14
Petanceska, S.S.15
Refolo, L.M.16
-
90
-
-
2442456925
-
Identification of insulin-responsive regions in the HMGCoA reductase promoter
-
Osborne AR, Pollock VV, Lagor WR, Ness GC (2004) Identification of insulin-responsive regions in the HMGCoA reductase promoter. Biochem Biophys Res Commun 318(4):814-818
-
(2004)
Biochem Biophys Res Commun
, vol.318
, Issue.4
, pp. 814-818
-
-
Osborne, A.R.1
Pollock, V.V.2
Lagor, W.R.3
Ness, G.C.4
-
91
-
-
0033919190
-
Introducing a new component of the metabolic syndrome: Low cholesterol absorption
-
Simonen P, Gylling H, Howard AN, Miettinen TA (2000) Introducing a new component of the metabolic syndrome: low cholesterol absorption. Am J Clin Nutr 72(1):82-88
-
(2000)
Am J Clin Nutr
, vol.72
, Issue.1
, pp. 82-88
-
-
Simonen, P.1
Gylling, H.2
Howard, A.N.3
Miettinen, T.A.4
-
92
-
-
0036726421
-
Diabetes contributes to cholesterol metabolism regardless of obesity
-
Simonen PP, Gylling HK, Miettinen TA (2002) Diabetes contributes to cholesterol metabolism regardless of obesity. Diabetes Care 25(9):1511-1515
-
(2002)
Diabetes Care
, vol.25
, Issue.9
, pp. 1511-1515
-
-
Simonen, P.P.1
Gylling, H.K.2
Miettinen, T.A.3
-
93
-
-
0028965012
-
Insulin suppresses bile acid synthesis in cultured rat hepatocytes by down-regulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase gene transcription
-
Twisk J, Hoekman MF, Lehmann EM, Meijer P, Mager WH, Princen HM (1995) Insulin suppresses bile acid synthesis in cultured rat hepatocytes by down-regulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase gene transcription. Hepatology 21(2):501-510
-
(1995)
Hepatology
, vol.21
, Issue.2
, pp. 501-510
-
-
Twisk, J.1
Hoekman, M.F.2
Lehmann, E.M.3
Meijer, P.4
Mager, W.H.5
Princen, H.M.6
-
95
-
-
15244350991
-
Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: Relevance to Alzheimer's disease
-
de la Monte SM, Wands JR (2005) Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. J Alzheimers Dis 7(1):45-61
-
(2005)
J Alzheimers Dis
, vol.7
, Issue.1
, pp. 45-61
-
-
de la Monte, S.M.1
Wands, J.R.2
-
96
-
-
0033378682
-
A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease
-
Frolich L, Blum-Degen D, Riederer P, Hoyer S (1999) A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease. Ann N Y Acad Sci 893:290-293
-
(1999)
Ann N Y Acad Sci
, vol.893
, pp. 290-293
-
-
Frolich, L.1
Blum-Degen, D.2
Riederer, P.3
Hoyer, S.4
-
97
-
-
0031928535
-
Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis
-
Hoyer S (1998) Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J Neural Transm 105(4-5):415-422
-
(1998)
J Neural Transm
, vol.105
, Issue.4-5
, pp. 415-422
-
-
Hoyer, S.1
-
98
-
-
22144444924
-
Alzheimer's disease: Interactions between cholinergic functions and beta-amyloid
-
Yan Z, Feng J (2004) Alzheimer's disease: interactions between cholinergic functions and beta-amyloid. Curr Alzheimer Res 1(4):241-248
-
(2004)
Curr Alzheimer Res
, vol.1
, Issue.4
, pp. 241-248
-
-
Yan, Z.1
Feng, J.2
-
99
-
-
27844472159
-
Increased risk of Alzheimer's disease in Type II diabetes: Insulin resistance of the brain or insulin-induced amyloid pathology?
-
Biessels GJ, Kappelle LJ (2005) Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem Soc Trans 33(Pt 5):1041-1044
-
(2005)
Biochem Soc Trans
, vol.33
, Issue.PART 5
, pp. 1041-1044
-
-
Biessels, G.J.1
Kappelle, L.J.2
-
100
-
-
33646093461
-
Comparison of protective effects of aspirin, d-penicillamine and vitamin E against high glucose-mediated toxicity in cultured endothelial cells
-
Zhang J, Slevin M, Duraisamy Y, Gaffney JA, Smith C, Ahmed N (2006) Comparison of protective effects of aspirin, d-penicillamine and vitamin E against high glucose-mediated toxicity in cultured endothelial cells. Biochim Biophys Acta 1762(5):551-557
-
(2006)
Biochim Biophys Acta
, vol.1762
, Issue.5
, pp. 551-557
-
-
Zhang, J.1
Slevin, M.2
Duraisamy, Y.3
Gaffney, J.A.4
Smith, C.5
Ahmed, N.6
-
101
-
-
26044444093
-
Inhibition of PI-3 kinase/Akt/mTOR, but not calcineurin signaling, reverses insulin-like growth factor I-induced protection against glucose toxicity in cardiomyocyte contractile function
-
Li SY, Fang CX, Aberle NS 2nd, Ren BH, Ceylan-Isik AF, Ren J. 2005 Inhibition of PI-3 kinase/Akt/mTOR, but not calcineurin signaling, reverses insulin-like growth factor I-induced protection against glucose toxicity in cardiomyocyte contractile function. J Endocrinol 186(3):491-503
-
(2005)
J Endocrinol
, vol.186
, Issue.3
, pp. 491-503
-
-
Li, S.Y.1
Fang, C.X.2
Aberle 2nd, N.S.3
Ren, B.H.4
Ceylan-Isik, A.F.5
Ren, J.6
-
102
-
-
33645036372
-
Intravenous glucose intake independently related to intensive care unit and hospital mortality: An argument for glucose toxicity in critically ill patients
-
der Voort PH, Feenstra RA, Bakker AJ, Heide L, Boerma EC, der Horst IC (2006) Intravenous glucose intake independently related to intensive care unit and hospital mortality: an argument for glucose toxicity in critically ill patients. Clin Endocrinol 64(2):141-145
-
(2006)
Clin Endocrinol
, vol.64
, Issue.2
, pp. 141-145
-
-
der Voort, P.H.1
Feenstra, R.A.2
Bakker, A.J.3
Heide, L.4
Boerma, E.C.5
der Horst, I.C.6
-
103
-
-
0034333018
-
Cognition and synaptic plasticity in diabetes mellitus
-
Gispen WH, Biessels GJ (2000) Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci 23(11):542-549
-
(2000)
Trends Neurosci
, vol.23
, Issue.11
, pp. 542-549
-
-
Gispen, W.H.1
Biessels, G.J.2
-
104
-
-
0142026832
-
Potential roles of insulin and IGF-1 in Alzheimer's disease
-
Gasparini L, Xu H (2003) Potential roles of insulin and IGF-1 in Alzheimer's disease. Trends Neurosci 26(8):404-406
-
(2003)
Trends Neurosci
, vol.26
, Issue.8
, pp. 404-406
-
-
Gasparini, L.1
Xu, H.2
-
105
-
-
0021437073
-
Alzheimer's disease. A metabolic systems degeneration?
-
Blass JP, Zemcov A (1984) Alzheimer's disease. A metabolic systems degeneration? Neurochem Pathol 2(2):103-114
-
(1984)
Neurochem Pathol
, vol.2
, Issue.2
, pp. 103-114
-
-
Blass, J.P.1
Zemcov, A.2
-
108
-
-
0031985192
-
Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease
-
Gasparini L, Racchi M, Binetti G, Trabucchi M, Solerte SB, Alkon D, Etcheberrigaray R, Gibson G, Blass J, Paoletti R, Govoni S (1998) Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease. FASEB J 12(1):17-34
-
(1998)
FASEB J
, vol.12
, Issue.1
, pp. 17-34
-
-
Gasparini, L.1
Racchi, M.2
Binetti, G.3
Trabucchi, M.4
Solerte, S.B.5
Alkon, D.6
Etcheberrigaray, R.7
Gibson, G.8
Blass, J.9
Paoletti, R.10
Govoni, S.11
-
109
-
-
0020685951
-
Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain
-
Sorbi S, Bird ED, Blass JP (1983) Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain. Ann Neurol 13(1):72-78
-
(1983)
Ann Neurol
, vol.13
, Issue.1
, pp. 72-78
-
-
Sorbi, S.1
Bird, E.D.2
Blass, J.P.3
-
110
-
-
0021813419
-
An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain
-
Sheu KF, Kim YT, Blass JP, Weksler ME (1985) An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain. Ann Neurol 17(5):444-449
-
(1985)
Ann Neurol
, vol.17
, Issue.5
, pp. 444-449
-
-
Sheu, K.F.1
Kim, Y.T.2
Blass, J.P.3
Weksler, M.E.4
-
111
-
-
0022001659
-
Altered calcium uptake in cultured skin fibroblasts from patients with Alzheimer's disease
-
Peterson C, Gibson GE, Blass JP (1985) Altered calcium uptake in cultured skin fibroblasts from patients with Alzheimer's disease. N Engl J Med 312(16):1063-1065
-
(1985)
N Engl J Med
, vol.312
, Issue.16
, pp. 1063-1065
-
-
Peterson, C.1
Gibson, G.E.2
Blass, J.P.3
-
112
-
-
0023191781
-
Altered metabolic properties of cultured skin fibroblasts in Alzheimer's disease
-
Sims NR, Finegan JM, Blass JP (1987) Altered metabolic properties of cultured skin fibroblasts in Alzheimer's disease. Ann Neurol 21(5):451-457
-
(1987)
Ann Neurol
, vol.21
, Issue.5
, pp. 451-457
-
-
Sims, N.R.1
Finegan, J.M.2
Blass, J.P.3
-
113
-
-
0021849778
-
Altered glucose metabolism in fibroblasts from patients with Alzheimer's disease
-
Sims NR, Finegan JM, Blass JP (1985) Altered glucose metabolism in fibroblasts from patients with Alzheimer's disease. N Engl J Med 313(10):638-639
-
(1985)
N Engl J Med
, vol.313
, Issue.10
, pp. 638-639
-
-
Sims, N.R.1
Finegan, J.M.2
Blass, J.P.3
-
114
-
-
0024162708
-
Normal replicative lifespan of Alzheimer skin fibroblasts
-
Balin AK, Baker AC, Leong IC, Blass JP (1988) Normal replicative lifespan of Alzheimer skin fibroblasts. Neurobiol Aging 9(2):195-198
-
(1988)
Neurobiol Aging
, vol.9
, Issue.2
, pp. 195-198
-
-
Balin, A.K.1
Baker, A.C.2
Leong, I.C.3
Blass, J.P.4
-
115
-
-
0023011598
-
Phosphofructokinase activity in fibroblasts from patients with Alzheimer's disease and ageand sex-matched controls
-
Sims NR, Blass JP (1986) Phosphofructokinase activity in fibroblasts from patients with Alzheimer's disease and ageand sex-matched controls. Metab Brain Dis 1(1):83-90
-
(1986)
Metab Brain Dis
, vol.1
, Issue.1
, pp. 83-90
-
-
Sims, N.R.1
Blass, J.P.2
-
116
-
-
0023270565
-
Phosphofructokinase activity in the brain in Alzheimer's disease
-
Sims NR, Blass JP, Murphy C, Bowen DM, Neary D (1987) Phosphofructokinase activity in the brain in Alzheimer's disease. Ann Neurol 21(5):509-510
-
(1987)
Ann Neurol
, vol.21
, Issue.5
, pp. 509-510
-
-
Sims, N.R.1
Blass, J.P.2
Murphy, C.3
Bowen, D.M.4
Neary, D.5
-
117
-
-
0025819896
-
Expression of 'Alzheimer antigens' in cultured skin fibroblasts
-
Blass JP, Baker AC, Ko L, Sheu RK, Black RS (1991) Expression of 'Alzheimer antigens' in cultured skin fibroblasts. Arch Neurol 48(7):709-717
-
(1991)
Arch Neurol
, vol.48
, Issue.7
, pp. 709-717
-
-
Blass, J.P.1
Baker, A.C.2
Ko, L.3
Sheu, R.K.4
Black, R.S.5
-
118
-
-
0028387219
-
Abnormality of the alpha-ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer's disease
-
Sheu KF, Cooper AJ, Koike K, Koike M, Lindsay JG, Blass JP (1994) Abnormality of the alpha-ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer's disease. Ann Neurol 35(3):312-318
-
(1994)
Ann Neurol
, vol.35
, Issue.3
, pp. 312-318
-
-
Sheu, K.F.1
Cooper, A.J.2
Koike, K.3
Koike, M.4
Lindsay, J.G.5
Blass, J.P.6
-
119
-
-
0030567762
-
Altered oxidation and signal transduction systems in fibroblasts from Alzheimer patients
-
Gibson G, Martins R, Blass J, Gandy S (1996) Altered oxidation and signal transduction systems in fibroblasts from Alzheimer patients. Life Sci 59(5-6):477-489
-
(1996)
Life Sci
, vol.59
, Issue.5-6
, pp. 477-489
-
-
Gibson, G.1
Martins, R.2
Blass, J.3
Gandy, S.4
-
120
-
-
0021810184
-
Red blood cell abnormalities in Alzheimer disease
-
Blass JP, Hanin I, Barclay L, Kopp U, Reding MJ (1985) Red blood cell abnormalities in Alzheimer disease. J Am Geriatr Soc 33(6):401-405
-
(1985)
J Am Geriatr Soc
, vol.33
, Issue.6
, pp. 401-405
-
-
Blass, J.P.1
Hanin, I.2
Barclay, L.3
Kopp, U.4
Reding, M.J.5
-
121
-
-
0022919081
-
Human red blood cell choline uptake with age and Alzheimer's disease
-
Sherman KA, Gibson GE, Blass JP (1986) Human red blood cell choline uptake with age and Alzheimer's disease. Neurobiol Aging 7(3):205-209
-
(1986)
Neurobiol Aging
, vol.7
, Issue.3
, pp. 205-209
-
-
Sherman, K.A.1
Gibson, G.E.2
Blass, J.P.3
-
122
-
-
0023198092
-
Diminished mitogen-induced calcium uptake by lymphocytes from Alzheimer patients
-
Gibson GE, Nielsen P, Sherman KA, Blass JP (1987) Diminished mitogen-induced calcium uptake by lymphocytes from Alzheimer patients. Biol Psychiatry 22(9):1079-1086
-
(1987)
Biol Psychiatry
, vol.22
, Issue.9
, pp. 1079-1086
-
-
Gibson, G.E.1
Nielsen, P.2
Sherman, K.A.3
Blass, J.P.4
-
123
-
-
0023627915
-
Mitochondrial function in brain tissue in primary degenerative dementia
-
Sims NR, Finegan JM, Blass JP, Bowen DM, Neary D (1987) Mitochondrial function in brain tissue in primary degenerative dementia. Brain Res 436(1):30-38
-
(1987)
Brain Res
, vol.436
, Issue.1
, pp. 30-38
-
-
Sims, N.R.1
Finegan, J.M.2
Blass, J.P.3
Bowen, D.M.4
Neary, D.5
-
124
-
-
0023732664
-
Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease
-
Gibson GE, Sheu KF, Blass JP, Baker A, Carlson KC, Harding B, Perrino P (1988) Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. Arch Neurol 45(8):836-840
-
(1988)
Arch Neurol
, vol.45
, Issue.8
, pp. 836-840
-
-
Gibson, G.E.1
Sheu, K.F.2
Blass, J.P.3
Baker, A.4
Carlson, K.C.5
Harding, B.6
Perrino, P.7
-
125
-
-
0023811452
-
Studies of transketolase abnormality in Alzheimer's disease
-
Sheu KF, Clarke DD, Kim YT, Blass JP, Harding BJ, DeCicco J (1988) Studies of transketolase abnormality in Alzheimer's disease. Arch Neurol 45(8):841-845
-
(1988)
Arch Neurol
, vol.45
, Issue.8
, pp. 841-845
-
-
Sheu, K.F.1
Clarke, D.D.2
Kim, Y.T.3
Blass, J.P.4
Harding, B.J.5
DeCicco, J.6
-
126
-
-
0027426832
-
Metabolic alterations common to neural and non-neural cells in Alzheimer's disease
-
Blass JP (1993) Metabolic alterations common to neural and non-neural cells in Alzheimer's disease. Hippocampus 3S:45-53
-
(1993)
Hippocampus
, vol.3 S
, pp. 45-53
-
-
Blass, J.P.1
-
127
-
-
0022072454
-
Cluster analysis of cognitive performance in elderly and demented subjects
-
Giaquinto S, Nolfe G, Calvani M. 1985 Cluster analysis of cognitive performance in elderly and demented subjects. Ital J Neurol Sci 6(2):157-165
-
(1985)
Ital J Neurol Sci
, vol.6
, Issue.2
, pp. 157-165
-
-
Giaquinto, S.1
Nolfe, G.2
Calvani, M.3
-
129
-
-
29044442270
-
A life-course approach to the aetiology of late-onset dementias
-
Whalley LJ, Dick FD, McNeill G. 2006 A life-course approach to the aetiology of late-onset dementias. Lancet Neurol 5(1):87-96
-
(2006)
Lancet Neurol
, vol.5
, Issue.1
, pp. 87-96
-
-
Whalley, L.J.1
Dick, F.D.2
McNeill, G.3
-
130
-
-
0026772772
-
Type 2 (non-insulin-dependent) diabetes mellitus: The thrifty phenotype hypothesis
-
Hales CN, Barker DJ (1992) Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35(7):595-601
-
(1992)
Diabetologia
, vol.35
, Issue.7
, pp. 595-601
-
-
Hales, C.N.1
Barker, D.J.2
-
131
-
-
4544359508
-
Cardiovascular risk factors and Alzheimer's disease
-
Luchsinger JA, Mayeux R (2004) Cardiovascular risk factors and Alzheimer's disease. Curr Atheroscler Rep 6(4):261-266
-
(2004)
Curr Atheroscler Rep
, vol.6
, Issue.4
, pp. 261-266
-
-
Luchsinger, J.A.1
Mayeux, R.2
-
132
-
-
30444447214
-
The role of insulin, insulin growth factor, and insulin-degrading enzyme in brain aging and Alzheimer's disease
-
Messier C, Teutenberg K (2005) The role of insulin, insulin growth factor, and insulin-degrading enzyme in brain aging and Alzheimer's disease. Neural Plast 12(4):311-328
-
(2005)
Neural Plast
, vol.12
, Issue.4
, pp. 311-328
-
-
Messier, C.1
Teutenberg, K.2
-
133
-
-
0027435481
-
Essential hypertension and cognitive function. The role of hyperinsulinemia
-
Kuusisto J, Koivisto K, Mykkanen L, Helkala EL, Vanhanen M, Hanninen T, Pyorala K, Riekkinen P, Laakso M (1993) Essential hypertension and cognitive function. The role of hyperinsulinemia. Hypertension 22(5):771-779
-
(1993)
Hypertension
, vol.22
, Issue.5
, pp. 771-779
-
-
Kuusisto, J.1
Koivisto, K.2
Mykkanen, L.3
Helkala, E.L.4
Vanhanen, M.5
Hanninen, T.6
Pyorala, K.7
Riekkinen, P.8
Laakso, M.9
-
134
-
-
9844229370
-
Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: Cross sectional population based study
-
Kuusisto J, Koivisto K, Mykkanen L, Helkala EL, Vanhanen M, Hanninen T, Kervinen K, Kesaniemi YA, Riekkinen PJ, Laakso M (1997) Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study. BMJ 315(7115):1045-1049
-
(1997)
BMJ
, vol.315
, Issue.7115
, pp. 1045-1049
-
-
Kuusisto, J.1
Koivisto, K.2
Mykkanen, L.3
Helkala, E.L.4
Vanhanen, M.5
Hanninen, T.6
Kervinen, K.7
Kesaniemi, Y.A.8
Riekkinen, P.J.9
Laakso, M.10
-
135
-
-
0037167548
-
-
Kernan WN, Inzucchi. SE, Viscoli CM, Brass LM, Bravata DM, Horwitz RI (2002) Insulin resistance and risk for stroke. Neurology 24;59(6):809-815
-
Kernan WN, Inzucchi. SE, Viscoli CM, Brass LM, Bravata DM, Horwitz RI (2002) Insulin resistance and risk for stroke. Neurology 24;59(6):809-815
-
-
-
-
136
-
-
0036788311
-
Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: The atherosclerosis risk in communities study
-
Golden SH, Folsom AR, Coresh J, Sharrett AR, Szklo M, Brancati F (2002) Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the atherosclerosis risk in communities study. Diabetes 51(10):3069-3076
-
(2002)
Diabetes
, vol.51
, Issue.10
, pp. 3069-3076
-
-
Golden, S.H.1
Folsom, A.R.2
Coresh, J.3
Sharrett, A.R.4
Szklo, M.5
Brancati, F.6
-
137
-
-
7744239901
-
The metabolic syndrome, inflammation, and risk of cognitive decline
-
Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AB (2004) The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292(18):2237-2242
-
(2004)
JAMA
, vol.292
, Issue.18
, pp. 2237-2242
-
-
Yaffe, K.1
Kanaya, A.2
Lindquist, K.3
Simonsick, E.M.4
Harris, T.5
Shorr, R.I.6
Tylavsky, F.A.7
Newman, A.B.8
-
138
-
-
0034611732
-
Central nervous system control of food intake
-
Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG (2000) Central nervous system control of food intake. Nature 404:661-671
-
(2000)
Nature
, vol.404
, pp. 661-671
-
-
Schwartz, M.W.1
Woods, S.C.2
Porte Jr, D.3
Seeley, R.J.4
Baskin, D.G.5
-
139
-
-
10644293209
-
Carnitine replacement in end-stage renal disease and hemodialysis
-
Calvani M, Benatti P, Mancinelli A, D'Iddio S, Giordano V, Koverech A, Amato A, Brass EP (2004) Carnitine replacement in end-stage renal disease and hemodialysis. Ann N Y Acad Sci 1033:52-66
-
(2004)
Ann N Y Acad Sci
, vol.1033
, pp. 52-66
-
-
Calvani, M.1
Benatti, P.2
Mancinelli, A.3
D'Iddio, S.4
Giordano, V.5
Koverech, A.6
Amato, A.7
Brass, E.P.8
-
140
-
-
23944482982
-
Central actions of adipocyte hormones
-
Ahima RS (2005) Central actions of adipocyte hormones. Trends Endocrinol Metab 16(7):307-313
-
(2005)
Trends Endocrinol Metab
, vol.16
, Issue.7
, pp. 307-313
-
-
Ahima, R.S.1
-
141
-
-
0030806382
-
Localization of leptin receptor in the human brain
-
Couce ME, Burguera B, Parisi JE, Jensen MD, Lloyd RV (1997) Localization of leptin receptor in the human brain. Neuroendocrinology 66:145-150
-
(1997)
Neuroendocrinology
, vol.66
, pp. 145-150
-
-
Couce, M.E.1
Burguera, B.2
Parisi, J.E.3
Jensen, M.D.4
Lloyd, R.V.5
-
142
-
-
0036212158
-
Leptin inhibits rat hippocampal neurons via activation of large conductance calcium-activated K+ channels
-
Shanley LJ, Irving AJ, Rae MG, Ashford ML, Harvey J (2002) Leptin inhibits rat hippocampal neurons via activation of large conductance calcium-activated K+ channels. Nat Neurosci 5:299-300
-
(2002)
Nat Neurosci
, vol.5
, pp. 299-300
-
-
Shanley, L.J.1
Irving, A.J.2
Rae, M.G.3
Ashford, M.L.4
Harvey, J.5
-
143
-
-
27844577342
-
Leptin: A potential cognitive enhancer?
-
Harvey J, Shanley LJ, O'Malley D, Irving AJ (2005) Leptin: a potential cognitive enhancer?. Biochem Soc Trans. 33(Pt 5):1029-1032
-
(2005)
Biochem Soc Trans
, vol.33
, Issue.PART 5
, pp. 1029-1032
-
-
Harvey, J.1
Shanley, L.J.2
O'Malley, D.3
Irving, A.J.4
-
144
-
-
0037008873
-
Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents
-
Li XL, Aou S, Oomura Y, Hori N, Fukunaga K, Hori T (2002) Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents. Neuroscience 113(3):607-615
-
(2002)
Neuroscience
, vol.113
, Issue.3
, pp. 607-615
-
-
Li, X.L.1
Aou, S.2
Oomura, Y.3
Hori, N.4
Fukunaga, K.5
Hori, T.6
-
145
-
-
33744948142
-
Leptin increases axonal growth cone size in developing mouse cortical neurons by convergent signals inactivating glycogen synthase kinase-3beta
-
Valerio A, Ghisi V, Dossena M, Tonello C, Giordano A, Frontini A, Ferrario M, Pizzi M, Spano P, Carruba MO, Nisoli E (2006) Leptin increases axonal growth cone size in developing mouse cortical neurons by convergent signals inactivating glycogen synthase kinase-3beta. J Biol Chem. 281(18):12950-12958
-
(2006)
J Biol Chem
, vol.281
, Issue.18
, pp. 12950-12958
-
-
Valerio, A.1
Ghisi, V.2
Dossena, M.3
Tonello, C.4
Giordano, A.5
Frontini, A.6
Ferrario, M.7
Pizzi, M.8
Spano, P.9
Carruba, M.O.10
Nisoli, E.11
-
146
-
-
10044238914
-
Obesity-related leptin regulates Alzheimer's Abeta
-
Fewlass DC, Noboa K, Pi-Sunyer FX, Johnston JM, Yan SD, Tezapsidis N (2004) Obesity-related leptin regulates Alzheimer's Abeta. FASEB J 18(15):1870-1878
-
(2004)
FASEB J
, vol.18
, Issue.15
, pp. 1870-1878
-
-
Fewlass, D.C.1
Noboa, K.2
Pi-Sunyer, F.X.3
Johnston, J.M.4
Yan, S.D.5
Tezapsidis, N.6
-
147
-
-
2342580152
-
Galanin in Alzheimer disease
-
Counts SE, Perez SE, Ginsberg SD, De Lacalle S, Mufson EJ (2003) Galanin in Alzheimer disease. Mol Interv 3(3):137-156
-
(2003)
Mol Interv
, vol.3
, Issue.3
, pp. 137-156
-
-
Counts, S.E.1
Perez, S.E.2
Ginsberg, S.D.3
De Lacalle, S.4
Mufson, E.J.5
-
148
-
-
0035857750
-
Distribution of galanin messenger RNA-expressing cells in murine brain and their regulation by leptin in regions of the hypothalamus
-
Cheung CC, Hohmann JG, Clifton DK, Steiner RA (2001) Distribution of galanin messenger RNA-expressing cells in murine brain and their regulation by leptin in regions of the hypothalamus. Neuroscience 103:423-432
-
(2001)
Neuroscience
, vol.103
, pp. 423-432
-
-
Cheung, C.C.1
Hohmann, J.G.2
Clifton, D.K.3
Steiner, R.A.4
-
149
-
-
0031707414
-
Dual relation between leptin and cortisol in humans is disturbed in Alzheimer's disease
-
Olsson T, Nasman B, Rasmuson S, Ahren B (1998) Dual relation between leptin and cortisol in humans is disturbed in Alzheimer's disease. Biol Psychiatry 44(5):374-376
-
(1998)
Biol Psychiatry
, vol.44
, Issue.5
, pp. 374-376
-
-
Olsson, T.1
Nasman, B.2
Rasmuson, S.3
Ahren, B.4
-
150
-
-
0035128130
-
Circulating leptin levels and weight loss in Alzheimer's disease patients
-
Power DA, Noel J, Collins R, O'Neill D (2001) Circulating leptin levels and weight loss in Alzheimer's disease patients. Dement Geriatr Cogn Disord 12(2):167-170
-
(2001)
Dement Geriatr Cogn Disord
, vol.12
, Issue.2
, pp. 167-170
-
-
Power, D.A.1
Noel, J.2
Collins, R.3
O'Neill, D.4
-
151
-
-
0041571668
-
-
Intebi AD, Garau L, Brusco I, Pagano M, Gaillard RC, Spinedi E. 2002-(2003) Alzheimer's disease patients display gender dimorphism in circulating anorectic adipokines. Neuroimmunomodulation 10(6):351-358
-
Intebi AD, Garau L, Brusco I, Pagano M, Gaillard RC, Spinedi E. 2002-(2003) Alzheimer's disease patients display gender dimorphism in circulating anorectic adipokines. Neuroimmunomodulation 10(6):351-358
-
-
-
-
152
-
-
33645037988
-
-
Koivisto AM, Helisalmi S, Pihlajamaki J, Moilanen L, Kuusisto J, Laakso M, Hiltunen M, Keijo K, Hanninen T, Helkala EL, Kervinen K, Kesaniemi YA, Soininen H (2005) Interleukin-6 promoter polymorphism and late-onset Alzheimer's disease in the Finnish population. J Neurogenet 19(3):155-161
-
Koivisto AM, Helisalmi S, Pihlajamaki J, Moilanen L, Kuusisto J, Laakso M, Hiltunen M, Keijo K, Hanninen T, Helkala EL, Kervinen K, Kesaniemi YA, Soininen H (2005) Interleukin-6 promoter polymorphism and late-onset Alzheimer's disease in the Finnish population. J Neurogenet 19(3):155-161
-
-
-
-
153
-
-
0036785316
-
Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer's disease
-
Oct;
-
Ikeda M, Brown J, Holland AJ, Fukuhara R, Hodges JR (2002) Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry Oct;73(4):371-376
-
(2002)
J Neurol Neurosurg Psychiatry
, vol.73
, Issue.4
, pp. 371-376
-
-
Ikeda, M.1
Brown, J.2
Holland, A.J.3
Fukuhara, R.4
Hodges, J.R.5
-
154
-
-
1642314515
-
Weight loss, nutritional status and physical activity in patients with Alzheimer's disease. A controlled study
-
Wang PN, Yang CL, Lin KN, Chen WT, Chwang LC, Liu HC (2004) Weight loss, nutritional status and physical activity in patients with Alzheimer's disease. A controlled study. J Neurol 251(3):314-320
-
(2004)
J Neurol
, vol.251
, Issue.3
, pp. 314-320
-
-
Wang, P.N.1
Yang, C.L.2
Lin, K.N.3
Chen, W.T.4
Chwang, L.C.5
Liu, H.C.6
-
155
-
-
0033540056
-
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
-
Kojima M, Hosoda H, Date Y, Nakazato M, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660
-
(1999)
Nature
, vol.402
, pp. 656-660
-
-
Kojima, M.1
Hosoda, H.2
Date, Y.3
Nakazato, M.4
Kangawa, K.5
-
156
-
-
0034687376
-
Ghrelin induces adiposity in rodents
-
Tschop M, Smiley DL, Heiman ML (2000) Ghrelin induces adiposity in rodents. Nature 407:908-913
-
(2000)
Nature
, vol.407
, pp. 908-913
-
-
Tschop, M.1
Smiley, D.L.2
Heiman, M.L.3
-
157
-
-
2942528459
-
Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin
-
van der Lely AJ, Tschop M, Heiman ML, Ghigo E (2004) Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 25:426-457
-
(2004)
Endocr Rev
, vol.25
, pp. 426-457
-
-
van der Lely, A.J.1
Tschop, M.2
Heiman, M.L.3
Ghigo, E.4
-
158
-
-
0038804193
-
Ghrelin as a potential anti-obesity target
-
Horvath TL, Castañeda T, Tang-Christensen M, Pagotto U, Tschop MH (2003) Ghrelin as a potential anti-obesity target. Curr Pharm Des 9:1383-1395
-
(2003)
Curr Pharm Des
, vol.9
, pp. 1383-1395
-
-
Horvath, T.L.1
Castañeda, T.2
Tang-Christensen, M.3
Pagotto, U.4
Tschop, M.H.5
-
159
-
-
15544385058
-
Ghrelin: Structure and function
-
Kojima M, Kangawa K (2005) Ghrelin: structure and function. Physiol Rev 85:495-522
-
(2005)
Physiol Rev
, vol.85
, pp. 495-522
-
-
Kojima, M.1
Kangawa, K.2
-
160
-
-
32844466699
-
Ghrelin does not influence gastric emptying in obese subjects
-
Valera Mora ME, Scarfone A, Valenza V, Calvani M, Greco AV, Gasbarrini G, Mingrone G (2005) Ghrelin does not influence gastric emptying in obese subjects. Obes Res 13(4):739-744
-
(2005)
Obes Res
, vol.13
, Issue.4
, pp. 739-744
-
-
Valera Mora, M.E.1
Scarfone, A.2
Valenza, V.3
Calvani, M.4
Greco, A.V.5
Gasbarrini, G.6
Mingrone, G.7
-
161
-
-
33646190291
-
Ghrelin-containing neuron in cerebral cortex and hypothalamus linked with the DVC of brainstem in rat
-
Hou Z, Miao Y, Gao L, Pan H, Zhu S (2006) Ghrelin-containing neuron in cerebral cortex and hypothalamus linked with the DVC of brainstem in rat. Regul Pept 134(2-3):126-131
-
(2006)
Regul Pept
, vol.134
, Issue.2-3
, pp. 126-131
-
-
Hou, Z.1
Miao, Y.2
Gao, L.3
Pan, H.4
Zhu, S.5
-
162
-
-
33344479006
-
Ghrelin controls hippocampal spine synapse density and memory performance
-
Yamada KA, Sleeman MW, Tschop MH, Horvath TL (2006) Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci 9(3):381-388
-
(2006)
Nat Neurosci
, vol.9
, Issue.3
, pp. 381-388
-
-
Yamada, K.A.1
Sleeman, M.W.2
Tschop, M.H.3
Horvath, T.L.4
-
163
-
-
33344479006
-
Ghrelin controls hippocampal spine synapse density and memory performance
-
Diano S, Farr SA, Benoit SC, McNay EC, da Silva I, Horvath B, Gaskin FS, Nonaka N, Jaeger LB, Banks WA, Morley JE, Pinto S, Sherwin RS, Xu L, Yamada KA, Sleeman MW, Tschop MH, Horvath TL (2006) Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci 9(3):381-388
-
(2006)
Nat Neurosci
, vol.9
, Issue.3
, pp. 381-388
-
-
Diano, S.1
Farr, S.A.2
Benoit, S.C.3
McNay, E.C.4
da Silva, I.5
Horvath, B.6
Gaskin, F.S.7
Nonaka, N.8
Jaeger, L.B.9
Banks, W.A.10
Morley, J.E.11
Pinto, S.12
Sherwin, R.S.13
Xu, L.14
Yamada, K.A.15
Sleeman, M.W.16
Tschop, M.H.17
Horvath, T.L.18
-
164
-
-
0036511213
-
ACRP30-adiponectin: An adipokine regulating glucose and lipid metabolism
-
Berg AH, Combs TP, Scherer PE (2002) ACRP30-adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13:84-89
-
(2002)
Trends Endocrinol Metab
, vol.13
, pp. 84-89
-
-
Berg, A.H.1
Combs, T.P.2
Scherer, P.E.3
-
165
-
-
1842475503
-
Restoration of adiponectin pulsatility in severely obese subjects after weight loss
-
Calvani M, Scarfone A, Granato L, Mora EV, Nanni G, Castagneto M, Greco AV, Manco M, Mingrone G (2004) Restoration of adiponectin pulsatility in severely obese subjects after weight loss. Diabetes 53(4):939-947
-
(2004)
Diabetes
, vol.53
, Issue.4
, pp. 939-947
-
-
Calvani, M.1
Scarfone, A.2
Granato, L.3
Mora, E.V.4
Nanni, G.5
Castagneto, M.6
Greco, A.V.7
Manco, M.8
Mingrone, G.9
-
166
-
-
18844432308
-
Adiponectin and adiponectin receptors
-
Kadowaki T, Yamauchi T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26:439-451
-
(2005)
Endocr Rev
, vol.26
, pp. 439-451
-
-
Kadowaki, T.1
Yamauchi, T.2
-
167
-
-
0037066603
-
ACRP30, a new hormone controlling fat and glucose metabolism
-
Tsao TS, Lodish HF, Fruebis J (2002) ACRP30, a new hormone controlling fat and glucose metabolism. Eur JPharmacol 440:213-221
-
(2002)
Eur JPharmacol
, vol.440
, pp. 213-221
-
-
Tsao, T.S.1
Lodish, H.F.2
Fruebis, J.3
-
168
-
-
0037135523
-
Disruption of adiponectin causes insulin resistance and neointimal formation
-
Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H, Yano W, Froguel P, Nagai R, Kimura S, Kadowaki T, Noda, Tl (2002) Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277:25863-25866
-
(2002)
J Biol Chem
, vol.277
, pp. 25863-25866
-
-
Kubota, N.1
Terauchi, Y.2
Yamauchi, T.3
Kubota, T.4
Moroi, M.5
Matsui, J.6
Eto, K.7
Yamashita, T.8
Kamon, J.9
Satoh, H.10
Yano, W.11
Froguel, P.12
Nagai, R.13
Kimura, S.14
Kadowaki, T.15
Noda, T.16
-
169
-
-
0036063777
-
Diet-induced insulin resistance in mice lacking adiponectin-ACRP30
-
Maeda NShimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, Komuro R, Ouchi N, Kihara S, Tochino Y, Okutomi K, Horie M, Takeda S, Aoyama T, Funahashi T, Matsuzawa Y (2002) Diet-induced insulin resistance in mice lacking adiponectin-ACRP30. Nature Med 8:731-737
-
(2002)
Nature Med
, vol.8
, pp. 731-737
-
-
Maeda NShimomura, I.1
Kishida, K.2
Nishizawa, H.3
Matsuda, M.4
Nagaretani, H.5
Furuyama, N.6
Kondo, H.7
Takahashi, M.8
Arita, Y.9
Komuro, R.10
Ouchi, N.11
Kihara, S.12
Tochino, Y.13
Okutomi, K.14
Horie, M.15
Takeda, S.16
Aoyama, T.17
Funahashi, T.18
Matsuzawa, Y.19
-
170
-
-
17944365228
-
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
-
Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tob K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Med 7:941-946
-
(2001)
Nature Med
, vol.7
, pp. 941-946
-
-
Yamauchi, T.1
Kamon, J.2
Waki, H.3
Terauchi, Y.4
Kubota, N.5
Hara, K.6
Mori, Y.7
Ide, T.8
Murakami, K.9
Tsuboyama-Kasaoka, N.10
Ezaki, O.11
Akanuma, Y.12
Gavrilova, O.13
Vinson, C.14
Reitman, M.L.15
Kagechika, H.16
Shudo, K.17
Yoda, M.18
Nakano, Y.19
Tob, K.20
Nagai, R.21
Kimura, S.22
Tomita, M.23
Froguel, P.24
Kadowaki, T.25
more..
-
171
-
-
17544382289
-
AdipoQ is a novel adipose-specific gene dysregulated in obesity
-
Hu E, Liang P, Spiegelman BM (1996) AdipoQ is a novel adipose-specific gene dysregulated in obesity. J BiolChem 271:10697-10703
-
(1996)
J BiolChem
, vol.271
, pp. 10697-10703
-
-
Hu, E.1
Liang, P.2
Spiegelman, B.M.3
-
172
-
-
0034999667
-
Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia
-
Weyer C et al (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 1930-1935
-
-
Weyer, C.1
-
173
-
-
0034577326
-
Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes
-
Statnick MA et al (2000) Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diabetes Res 1:81-88
-
(2000)
Int J Exp Diabetes Res
, vol.1
, pp. 81-88
-
-
Statnick, M.A.1
-
174
-
-
0034096988
-
Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients
-
Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20:1595-1599
-
(2000)
Arterioscler Thromb Vasc Biol
, vol.20
, pp. 1595-1599
-
-
Hotta, K.1
Funahashi, T.2
Arita, Y.3
Takahashi, M.4
Matsuda, M.5
Okamoto, Y.6
Iwahashi, H.7
Kuriyama, H.8
Ouchi, N.9
Maeda, K.10
Nishida, M.11
Kihara, S.12
Sakai, N.13
Nakajima, T.14
Hasegawa, K.15
Muraguchi, M.16
Ohmoto, Y.17
Nakamura, T.18
Yamashita, S.19
Hanafusa, T.20
Matsuzawa, Y.21
more..
-
175
-
-
33644748270
-
Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells
-
Spranger J, Verma S, Gohring I, Bobbert T, Seifert J, Sindler AL, Pfeiffer A, Hileman SM, Tschop M, Banks WA (2006) Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes 55(1):141-147
-
(2006)
Diabetes
, vol.55
, Issue.1
, pp. 141-147
-
-
Spranger, J.1
Verma, S.2
Gohring, I.3
Bobbert, T.4
Seifert, J.5
Sindler, A.L.6
Pfeiffer, A.7
Hileman, S.M.8
Tschop, M.9
Banks, W.A.10
-
176
-
-
33947583334
-
-
Zuliani G, Ronzini M, Guerra G, Rossi L, Munari MR, Zurlo A, Volpato S, Atti AR, Ble A, Fellin RJ (2006) Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia. Psychiat Res (in press)
-
Zuliani G, Ronzini M, Guerra G, Rossi L, Munari MR, Zurlo A, Volpato S, Atti AR, Ble A, Fellin RJ (2006) Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia. Psychiat Res (in press)
-
-
-
|